ArticleRadiology case reports2026
FH-deficient uterine leiomyoma: A rare case report highlighting diagnostic and clinical challenges.
Article in Radiology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fumarate hydratase (FH)-deficient uterine leiomyomas are a rare subtype of fibroids with distinctive histological and immunohistochemical features. We report the case of a 44-year-old nulligravida presenting with chronic pelvic pain for 2 years and an enlarged abdomen. Pelvic ultrasound revealed a polymyomatous uterus with the largest myoma measuring 14 cm, and MRI confirmed multiple leiomyomas with signs of pelvic congestion. The patient underwent polymyomectomy, and histopathological analysis identified an Fumarate hydratase (FH)-deficient leiomyoma. This entity is important to recognize given its potential association with Hereditary Leiomyomatosis and Renal Cell Carcinoma (HLRCC), warranting careful diagnosis, appropriate surgical management, and consideration of genetic counseling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.